Table 6 Clinical, preprocessing and analysis factors implicated in heterogeneity of findings for functional connectivity (patients vs controls).

From: Resting-state EEG and MEG gamma frequencies in schizophrenia: a systematic review and exploratory power-spectrum meta-analysis

Parameter

Studies with increased gamma functional connectivity (N = 4)

Studies with decreased gamma functional connectivity (N = 6)

Studies with mixed results (N = 4)

Studies with no group differences (N = 6)

Total sample size

147

179

168

260

Age

29 [27 | 31.3]

28.1 [27.3 | 40]

40.4 [37 | 40.4]

24 [23.5 | 36.7]

Sex (F)

32% [26 | 36.5]

48% [31 | 53]

21% [21 | 21]

24% [23 | 37]

Duration of illness (months)

63.2 [43.7 | 117.1]

24.2 [18.4 | 47.1]

12.7 [12.7 | 12.7]

19.3 [17.7 | 48.1]

Severity of disease (PANSS total score)

75.8 [70 | 78.2]

64.6 [61.4 | 72.2]

91 [91 | 91]

62.1 [58 | 68]

Medication status

Medicated: 1

Medicated:3

Medicated: 3

Medicated: 4

Unmedicated: 2

Unmedicated: 0

Unmedicated: 0

Unmedicated: 0

Mixeda: 1

Mixeda: 2

Mixeda: 0

Mixeda: 2

Na: 0

Na: 1

Na: 1

Na: 0

Recording method

EEG: 4

EEG: 3

EEG: 4

EEG: 3

MEG: 0

MEG: 2

MEG: 0

MEG: 3

Number of channels/sensors

114 [32 | 194]

45 [20 | 306]

64 [64 | 64]

25 [21 | 148]

Recording duration

5’ [3 | 8]

7’ [5 | 12]

4’ [4 | 5]

7’ [5 | 10]

Eyes open/eyes closed

Open: 0

Open: 2

Open: 1

Open: 1

Closed: 4

Closed: 3

Closed: 3

Closed: 5

Na: 0

Na: 1

Na: 0

Na: 0

Gamma sub-band

30–50 hz: 2

30–50 hz: 3

30–50 hz: 1

30–50 hz: 4

30–70 hz: 1

30–70 hz: 2

30–70 hz: 3

30–70 hz: 2

30–100 hz: 1

30–100 hz: 1

30–100 hz: 0

30–100 hz: 0

Artifact correction method

ICA: 1

ICA: 0

ICA: 0

ICA:

ICA+other: 1

ICA+other: 1

ICA+other: 3

ICA+other:

Other: 2

Other: 4

Other: 1

Other:

Na: 0

Na: 1

Na: 0

Na:

Absolute or relative power

Absolute: 2

Absolute: 4

Absolute: 1

Absolute: 2

Relative: 1

Relative: 1

Relative: 0

Relative: 1

Na: 1

Na: 1

Na: 3

Na: 3

Brain region

Whole brain: 1

Whole brain: 3

Whole brain: 0

/

Multiple: 3

Multiple: 3

Multiple: 4

Frontal: 0

Frontal: 0

Frontal: 0

Temporal: 0

Temporal: 0

Temporal: 0

Central: 0

Central: 0

Central: 0

Parietal: 0

Parietal: 0

Parietal: 0

Occipital: 0

Occipital: 0

Occipital: 0

Source localization method

LORETA: 2

LORETA: 2

LORETA: 1

LORETA: 1

Equivalent current dipole: 0

Equivalent current dipole: 0

Equivalent current dipole: 0

Equivalent current dipole: 0

Minimum norm estimates: 0

Minimum norm estimates: 0

Minimum norm estimates: 0

Minimum norm estimates: 2

DICS: 0

DICS: 0

DICS: 0

DICS: 0

BESA: 0

BESA: 0

BESA: 0

BESA: 0

Others: 0

Others: 1

Others: 0

Others: 1

Sensor-level spectral power vs source estimates

Sensor: 2

Sensor: 3

Sensor: 3

Sensor: 2

Source: 2

Source: 3

Source: 0

Source: 4

Both: 0

Both: 0

Both: 1

Both: 0

Functional connectivity method:

Phase lag index: 0

Phase lag index: 2

Phase lag index: 3

Phase lag index: 2

Coherence: 1

Coherence: 2

Coherence: 0

Coherence: 0

Envelope: 0

Envelope: 0

Envelope: 0

Envelope: 2

Various: 0

Various: 1

Various: 1

Various: 0

Others: 3

Others: 1

Others: 0

Others: 2

  1. Local or whole brain spectral changes compared to healthy controls are considered. Values of numeric variables are expressed as median [p25 | p75]. For categorical variables, the number of studies is reported.
  2. DICS Dynamic Imaging of Coherent Sources, BESA brain electrical source analysis.
  3. Studies from Chang et al., 2024 (mixed results) and Alamian et al., 2020 (no difference) was considered 2 times, for eyes open and closed conditions;
  4. aCohort including both medicated and unmedicated patients.